Related Experiment Video

Updated: Jun 3, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

[Association study between TNFSF4 and coronary heart disease]

Min-Zhi Chen1, Guang-Hui Cheng, Long Ma

  • 1Institute of Medical Genetics, School of Medicine, Shandong University, Jinan 250012, China. chenminzhi11205@163.com

Yi Chuan = Hereditas
|March 16, 2011
PubMed

Insights

Tumor necrosis factor superfamily member 4 (TNFSF4) is linked to coronary heart disease (CHD) in the Chinese Han population. Haplotype analysis revealed significant associations, supporting TNFSF4 as a susceptibility gene for CHD.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research

Context:

  • Previous studies on TNFSF4 as an atherosclerosis susceptibility gene yielded inconsistent results across populations.
  • Investigating the role of TNFSF4 in coronary heart disease (CHD) within the Chinese Han population is crucial due to conflicting prior findings.

Purpose:

  • To analyze the association between five single-nucleotide polymorphisms (SNPs) of the TNFSF4 gene and CHD in the Chinese Han population.
  • To apply traditional statistical methods and principal component score-based logistic regression to evaluate the genetic contribution of TNFSF4 to CHD.

Summary:

  • Analysis of five TNFSF4 SNPs (rs1234314, rs45454293, rs3850641, rs1234313, rs3861950) in 498 cases and 509 controls showed no statistical significance for individual SNPs in logistic regression after Bonferroni correction.
  • Haplotype analysis identified significant differences in frequencies for six haplotypes between cases and controls (e.g., CTAGT, GCGAC).
  • Principal component score-based logistic regression indicated statistical significance for the first principal component (P=0.0236), suggesting an overall genetic contribution.

Impact:

  • The findings suggest that TNFSF4 is a susceptibility gene for coronary heart disease (CHD) in the Chinese Han population.
  • This study contributes to understanding the genetic basis of CHD and highlights the importance of population-specific genetic factors.
  • The results warrant further investigation into the specific haplotypes and their functional mechanisms in CHD pathogenesis.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...